Could an FDA Nod for MR-141 Give Viatris (VTRS) and Opus Genetics (IRD) a Presbyopia Payoff?
Viatris Inc. (NASDAQ:VTRS) and Opus Genetics, Inc. (NASDAQ:IRD) are waiting on the same decision.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 9,000,000 | $43,560,000 | 0.76% | |
| 2. | Caligan Partners David Johnson | 5,960,972 | $28,851,104 | -2% | 1.77% |
| 3. | Cormorant Asset Management Bihua Chen | 5,500,000 | $26,620,000 | 1.79% | |
| 4. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 4,569,528 | $22,116,516 | +50% | 0.7% |
| 5. | Boxer Capital Aaron Davis And Christopher Fuglesang | 4,533,660 | $21,942,914 | +62% | 1.91% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.97 | 83,000 | $163,418.70 | 83,000 | 2025-12-29 | Filing | |
| $1.98 | 81,000 | $160,274.70 | 1,891,430 | 2025-12-29 | Filing | |
| $0.98 | 100,000 | $97,600.00 | 599,150 | 2024-12-26 | Filing | |
| $0.98 | 10,000 | $9,834.00 | 342,800 | 2024-11-21 | Filing | |
| $1.02 | 9,706 | $9,942.83 | 492,950 | 2024-11-18 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.90 | 28,258 | $110,183.59 | 2,010,636 | 2026-11-03 | Filing | |
| $3.57 | 4,767 | $16,994.36 | 286,673 | 2026-10-23 | Filing | |
| $3.53 | 25,520 | $90,128.98 | 670,917 | 2026-10-23 | Filing | |
| $3.55 | 7,669 | $27,235.69 | 696,437 | 2026-10-23 | Filing | |
| $3.55 | 14,000 | $49,649.60 | 542,375 | 2026-10-23 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,236,178 | $25,343,101 | 0% | |
| 2. | 3,683,429 | $17,827,796 | 52.17% | |
| 3. | 3,273,451 | $15,843,503 | 0% | |
| 4. | 1,810,968 | $8,767,030 | 0% | |
| 5. | 1,330,398 | $6,439,126 | 0% |